Multifunctional hybrid graphene oxide for circulating tumor cell isolation and analysis

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Metastatic disease causes over 90% of cancer deaths, highlighting the need for early detection methods.
• Circulating tumor cells (CTCs) are rare and heterogeneous, posing significant challenges for their use as a liquid biopsy.
• Advancements in nanoscience enable the development of novel tools for CTC isolation and identification.

Purpose of the Study:

• To review the development of graphene oxide (GO) based nanoarchitectures for CTC isolation and identification.
• To discuss design criteria for hybrid GO nanoarchitectures targeting heterogeneous CTCs.
• To explore the clinical translation prospects of GO-based nanotechnology for CTC detection.

Main Methods:

• Review of recent advancements in graphene oxide (GO) based nanoarchitectures.
• Discussion of 0D, 2D, and 3D multifunctional hybrid GO materials for CTC capture.
• Analysis of design principles for selective CTC isolation and identification.

Main Results:

• Hybrid GO nanoarchitectures demonstrate significant potential for the diagnosis of circulating tumor cells (CTCs).
• Various nanoarchitectures have been designed using multifunctional hybrid graphene oxide.
• These platforms show promise for the selective capture and accurate identification of heterogeneous CTCs.

Conclusions:

• Graphene oxide based nanotechnology offers a powerful platform for CTC diagnosis.
• Significant challenges remain in the clinical translation of GO-based CTC identification.
• Future prospects involve refining these nanoarchitectures for widespread clinical application.